Top Markets
Coin of the day
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Kedudukan dalam Saham #13314
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Harga Saham
$0.30780727
Modal Pasaran
$94.19M
Perubahan (1 hari)
-0.19%
Perubahan (1 tahun)
-34.73%
Negara
FR
Perdagangan Sensorion SA (ALSEN)

Kategori

Sejarah harga saham bagi Sensorion SA (ALSEN)
Harga penutupan tertinggi: $0.30 pada 2026-07-01

Harga penutupan terendah: $4.88 pada 2015-04-01
Sejarah harga saham Sensorion SA dari 2015 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -14.19%
2025 -35.43%
2024 42.20%
2023 21.00%
2022 -80.41%
2021 12.23%
2020 121.36%
2019 -30.56%
2018 -66.86%
2017 -29.31%
2016 -42.01%
2015 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$49.28 -28.51%
DK
$482.59 2.93%
US
$663.74 16.91%
US
$281.36 41.09%
BE
$869.87 55.27%
NL